BioCentury
ARTICLE | Financial News

Oxford Immunotec sets IPO range

November 9, 2013 1:54 AM UTC

Diagnostic company Oxford Immunotec Global plc (Abingdon, U.K.) amended its IPO and now plans to sell 5.4 million shares at $13-$15. At the $14 midpoint, the company would raise $75 million and be valued at $229.1 million. The company filed to raise up to $86.3 million in the offering last month. JPMorgan; Piper Jaffray; Cowen; and Baird are underwriters. ...